Impurose 10 Tablet contains Rosuvastatin 10 mg, a potent lipid-lowering agent belonging to the statin class of medications. It is primarily indicated for the treatment of hypercholesterolemia and mixed dyslipidemia to reduce elevated total cholesterol, low-density lipoprotein cholesterol (LDL-C), apolipoprotein B, and triglycerides, while increasing high-density lipoprotein cholesterol (HDL-C). Rosuvastatin acts by selectively inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, leading to decreased cholesterol production and increased clearance of LDL particles from the bloodstream. Impurose 10 is prescribed as an adjunct to diet and lifestyle modifications, including exercise, weight reduction, and smoking cessation, to lower the risk of cardiovascular events such as myocardial infarction, stroke, and the need for revascularization procedures in patients with established coronary artery disease or multiple risk factors. The tablet is typically administered once daily, with or without food, and dosage adjustments may be required based on therapeutic response and patient tolerance. Common adverse effects include headache, myalgia, and gastrointestinal disturbances; however, serious side effects such as myopathy and hepatotoxicity are rare but warrant monitoring of liver enzymes and creatine kinase levels during therapy. Impurose 10 should be used cautiously in patients with hepatic impairment and contraindicated during pregnancy and lactation.